Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India
The company’s Growth Portfolio delivered $6.2 billion in revenue
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
But acquisition charges drag earnings into loss
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Health innovations are viewed more positively than food and agricultural technologies
Subscribe To Our Newsletter & Stay Updated
